Clearday, Inc. is a non-acute longevity healthcare services company. The Company is engaged in making care options more accessible, affordable, and empowering for older Americans and is dedicated to enhancing the lives of adults through cognitive care solutions. It is engaged in owning and operating residential care facilities in the challenging senior care venues (memory and Alzheimerâ€™s treatment), to develop its purpose-built longevity-tech platform. Its longevity-tech platform intentionally moves its focus from a facility-driven real estate business to a healthcare technologies business that is designed to capture the massive unmet senior care need. Its digital service, Clearday at Home, brings an intersection of telehealth, software-as-a-service (SaaS), and subscription-based content.

Employees

225

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - OTC Markets Other stock markets 17:32:51 09/07/2026 +04			5-day change	1st Jan Change
0.002500 ^USD	0.00%		0.00%	+127.27%

02/05/24	Clearday, Inc. Announces the Resignation of Jeffrey Coleman as Board Member	CI
24/04/24	Clearday Introduces Digital Assistants in Residential Communities	CI

Market Cap	24.08M 21.15M 19.67M 18.05M 33.91M 2.32B 34.43M 234M 91.25M 1.14B 90.4M 88.45M 3.94B	P/E 2021	-1.11x	P/E 2022	-0.47x
Enterprise Value	68.95M 60.56M 56.32M 51.68M 97.1M 6.64B 98.6M 669M 261M 3.26B 259M 253M 11.29B	EV / Sales 2021	6.22x	EV / Sales 2022	4.45x
Free-Float	98.8%	Yield 2021 *	-	Yield 2022	-

02/05/24	Clearday, Inc. Announces the Resignation of Jeffrey Coleman as Board Member	CI
24/04/24	Clearday Introduces Digital Assistants in Residential Communities	CI
21/03/24	Clearday, Inc. announced that it has received $1.464 million in funding from Mast Hill Management, LLC	CI
23/02/24	Clearday, Inc. Enters into Certain First Amended and Restated Promissory Note	CI
16/01/24	Clearday, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
17/10/23	Clearday, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
19/07/23	Clearday, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
26/05/23	Clearday, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
25/05/23	Clearday, Inc. Auditor Raises 'Going Concern' Doubt	CI
17/02/23	Clearday, Inc. announced that it has received $0.135 million in funding	CI
08/02/23	Clearday's Elder Care "AI" Gets Major Vote of Confidence with an Expanded Contract with the Veterans Administration (VA)	CI
24/01/23	Clearday, Inc. signed a letter of intent to acquire Two adjacent senior living properties Portfolio in the Southeastern United States for approximately $44 million.	CI
13/01/23	Clearday, Inc. announced that it has received $0.6804 million in funding from Mast Hill Management, LLC	CI

21/11/24	Clearday : James Walesa Presents Innovations in Dementia Care at Wharton Health Care Management Conference	PU
15/11/24	Clearday Clubs Participates in University of Pennsylvania, Wharton Health Care Management Health Care Management Alumni Association Conference	AQ
22/07/24	Tech Centric Healthcare Services Company Continues To Move Forward With Its Business Combination and Exchange Listing	AQ
13/06/24	Clearday Supports National Health Observances	AQ
03/05/24	Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success - Updated	AQ

Clearday, Inc. Stock

Stocks

CLRD

US1847911013

Healthcare Facilities & Services

Valuation: Clearday, Inc.

Chart: Clearday, Inc.

Latest news : Clearday, Inc.

Press Releases: Clearday, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Clearday, Inc.

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Current month	+108.33%
1 month	+108.33%
6 months	-50.00%
Current year	+127.27%

1 month	0		0
Current year	0		0.1
1 year	0		0.75
3 years	0		1.45
5 years	0		5.45
10 years	0		5.45

Manager	Title	Age	Since
James Walesa CEO	Chief Executive Officer	65	11/05/1987
B. J. Parrish DFI	Director of Finance/CFO	55	23/11/2022
Ginny Connolly IRC	Investor Relations Contact	-	-

Director	Title	Age	Since
James Walesa CHM	Chairman	65	11/05/1987
B. J. Parrish BRD	Director/Board Member	55	09/09/2021
Alan Channing BRD	Director/Board Member	82	09/09/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
30/12/22	James Walesa	Buy	Chief Executive Officer	1,776,436	9.3410%
10/06/22	James Walesa	Buy	Chief Executive Officer	157,407	0.8855%
10/06/22	Alan Channing	Buy	Director	24,453	0.1376%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CLEARDAY, INC.	0.00%	0.00%	-51.92%	-99.63%	70.85K
CVS HEALTH CORPORATION	+0.80%	+0.25%	+83.39%	+41.86%	137B
HCA HEALTHCARE, INC.	+1.51%	+2.97%	+11.92%	+34.02%	84.78B
FRESENIUS SE & CO. KGAA	+2.22%	+4.96%	+3.79%	+56.43%	28.09B
QUEST DIAGNOSTICS INCORPORATED	-0.02%	+8.15%	+32.55%	+58.21%	25.15B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.32%	0.00%	-14.44%	-27.43%	20.05B
TENET HEALTHCARE CORPORATION	+17.17%	+19.64%	+57.16%	+203.29%	20.09B
DAVITA INC.	+0.50%	-0.65%	+62.63%	+130.60%	15.12B
REDE D'OR SÃO LUIZ S.A.	-0.86%	-6.71%	+2.39%	-7.05%	14.49B
FRESENIUS MEDICAL CARE AG	+0.65%	+2.44%	-5.50%	-10.95%	13.07B
Average	+2.33%	+3.10%	+18.20%	+37.93%	35.83B
Weighted average by Cap.	+1.88%	+2.65%	+42.33%	+47.30%

	2021	2022
Net sales	12.88M 11.31M 10.52M 9.66M 18.14M 1.24B 18.42M 125M 48.81M 610M 48.36M 47.32M 2.11B	12.49M 10.97M 10.2M 9.36M 17.59M 1.2B 17.86M 121M 47.32M 591M 46.88M 45.87M 2.04B
Net income	-19.69M -17.29M -16.08M -14.75M -27.72M -1.9B -28.15M -191M -74.6M -932M -73.9M -72.31M -3.22B	-14.31M -12.57M -11.69M -10.72M -20.15M -1.38B -20.46M -139M -54.22M -677M -53.71M -52.55M -2.34B
Net Debt	49.37M 43.37M 40.33M 37.01M 69.53M 4.75B 70.6M 479M 187M 2.34B 185M 181M 8.08B	44.87M 39.41M 36.65M 33.63M 63.19M 4.32B 64.16M 435M 170M 2.12B 168M 165M 7.34B